HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic

HOPE Therapeutics, Inc., (“HOPE,” the “Company”), a medical and technology driven company, and a wholly-owned subsidiary of NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), announces signing a non-binding Letter of Intent (LOI) for acquisition of a premier West Coast Interventional Psychiatric Clinic. The clinic to be acquired will establish HOPE’s model for clinics operating in the Company’s network across the country, providing the highest standard of care to patients suffering from problems such as suicidal depression, PTSD and other CNS disorders.

Read the full article: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic //

Source: https://www.prnewswire.com/news-releases/hope-therapeutics-inc-and-nrx-pharmaceuticals-inc-nasdaqnrxp-announce-signing-of-a-letter-of-intent-to-acquire-a-premier-west-coast-interventional-psychiatric-clinic-302266412.html

Scroll to Top